Skip to content

Oric Pharmaceuticals

US · ORIC #3089 by market cap Listed 2020
7.36 -0.34 -4.42%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.9 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
120.83% -1.90pp
Institutions
222 +12
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund43.28%
Hedge Fund38.04%
VC/PE Fund31.87%
Public Company5.18%
Individual/Insider1.04%
Private Company1.01%
Family Office/Trust0.99%
Government Pension Fund0.18%
Insurance Company0.17%

Top holders as of 2026-06-30

Nextech Invest Ltd. 6.91% · 7.16M sh
BlackRock 6.73% · 6.98M sh
EcoR1 Capital, LLC 6.49% · 6.73M sh
T. Rowe Price Group, Inc. 6.38% · 6.62M sh
Viking Global Investors LP 4.95% · 5.13M sh
SR One Capital Management, LP 4.45% · 4.62M sh
VR Management, LLC 4.17% · 4.32M sh
State Street Global Advisors 3.98% · 4.13M sh
New Enterprise Associates, Inc. 3.97% · 4.12M sh
Vanguard Capital Management, LLC 3.93% · 4.07M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 27 sells

NameRoleStake
Jacob Chacko Chief Executive Officer 0.56%
Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board 0.23%
Lori Kunkel Independent Director 0.08%
Dominic Piscitelli Chief Financial Officer 0.07%
Pratik Multani Chief Medical Officer 0.07%
Angie You Independent Director 0.03%
Mardi Dier Independent Director --
Steven Hoerter Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-19 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -14,000 $4.36–13.53
2026-09-30 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -3,200 $12.91
2026-09-30 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $1.60–12.91
2026-09-27 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -13,400 $4.36–13.53
2026-09-23 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -600 $4.36–13.51
2026-08-25 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -77,000 $4.36–13.69
2026-07-23 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Open Market Disposition -9,600 $12.02
2026-07-23 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Derivative Exercise and Sale -3,500 $1.60–12.02
2026-07-05 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -300 $12.00
2026-02-23 Dominic Piscitelli Chief Financial Officer Derivative Exercise and Sale -52,000 $4.36–13.51
2026-01-15 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Automatic Disposition -6,700 $12.00
2026-01-01 Pratik Multani Chief Medical Officer Other Derivative Acquisition +35,500 --
2026-01-01 Pratik Multani Chief Medical Officer Other Derivative Acquisition +214,000 $8.17
2026-01-01 Angie You Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Richard Heyman Founder, Independent Chairman & Member of Scientific Advisory Board Other Derivative Acquisition +40,000 $8.17
2026-01-01 Lori Kunkel Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Mardi Dier Independent Director Other Derivative Acquisition +40,000 $8.17
2026-01-01 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +112,500 --
2026-01-01 Jacob Chacko Chief Executive Officer Other Derivative Acquisition +675,000 $8.17
2026-01-01 Steven Hoerter Independent Director Other Derivative Acquisition +40,000 $8.17

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Oric Pharmaceuticals discussion 0 comments

Add a comment